WallStreetZenWallStreetZen

NASDAQ: VTYX
Ventyx Biosciences Inc Stock Forecast, Predictions & Price Target

Analyst price target for VTYX

Based on 5 analysts offering 12 month price targets for Ventyx Biosciences Inc.
Min Forecast
$2.00-32.89%
Avg Forecast
$9.80+228.86%
Max Forecast
$16.00+436.91%

Should I buy or sell VTYX stock?

Based on 5 analysts offering ratings for Ventyx Biosciences Inc.
Buy
Strong Buy
2 analysts 40%
Buy
1 analysts 20%
Hold
2 analysts 40%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their VTYX stock forecasts and price targets.

VTYX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-06-06
lockedlocked$00.00+00.00%2024-06-06
lockedlocked$00.00+00.00%2024-03-13
lockedlocked$00.00+00.00%2024-03-12
lockedlocked$00.00+00.00%2023-12-18

1 of 1

Forecast return on equity

Is VTYX forecast to generate an efficient return?
Company
1.84%
Industry
76.1%
Market
79%
VTYX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is VTYX forecast to generate an efficient return on assets?
Company
1.7%
Industry
30.96%
VTYX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

VTYX earnings per share forecast

What is VTYX's earnings per share in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
-$2.31
Avg 2 year Forecast
-$2.37
Avg 3 year Forecast
-$1.20

VTYX revenue forecast

What is VTYX's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$333.5M
Avg 2 year Forecast
$353.0M
Avg 3 year Forecast
$710.5M

VTYX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VTYX$2.98$9.80+228.86%Buy
GLUE$4.16$11.00+164.42%Buy
RENB$1.43N/AN/A
CHRS$1.82$9.33+412.80%Strong Buy
ZVRA$4.98$15.00+201.20%Buy

Ventyx Biosciences Stock Forecast FAQ

Is Ventyx Biosciences Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: VTYX) stock is to Buy VTYX stock.

Out of 5 analysts, 2 (40%) are recommending VTYX as a Strong Buy, 1 (20%) are recommending VTYX as a Buy, 2 (40%) are recommending VTYX as a Hold, 0 (0%) are recommending VTYX as a Sell, and 0 (0%) are recommending VTYX as a Strong Sell.

If you're new to stock investing, here's how to buy Ventyx Biosciences stock.

What is VTYX's earnings growth forecast for 2024-2026?

(NASDAQ: VTYX) Ventyx Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.79%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.61%.

Ventyx Biosciences's earnings in 2024 is -$192,603,000.On average, 6 Wall Street analysts forecast VTYX's earnings for 2024 to be -$163,086,105, with the lowest VTYX earnings forecast at -$186,823,230, and the highest VTYX earnings forecast at -$145,933,617. On average, 5 Wall Street analysts forecast VTYX's earnings for 2025 to be -$167,224,416, with the lowest VTYX earnings forecast at -$219,252,923, and the highest VTYX earnings forecast at -$129,013,778.

In 2026, VTYX is forecast to generate -$84,366,551 in earnings, with the lowest earnings forecast at -$174,838,343 and the highest earnings forecast at $53,579,492.

What is VTYX's revenue growth forecast for 2026-2028?

(NASDAQ: VTYX) Ventyx Biosciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.85%.

Ventyx Biosciences's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast VTYX's revenue for 2026 to be $23,510,822,229, with the lowest VTYX revenue forecast at $23,510,822,229, and the highest VTYX revenue forecast at $23,510,822,229. On average, 2 Wall Street analysts forecast VTYX's revenue for 2027 to be $24,888,379,176, with the lowest VTYX revenue forecast at $2,305,328,156, and the highest VTYX revenue forecast at $47,471,430,196.

In 2028, VTYX is forecast to generate $50,092,595,359 in revenue, with the lowest revenue forecast at $7,296,680,862 and the highest revenue forecast at $92,888,509,857.

What is VTYX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: VTYX) forecast ROA is 1.7%, which is lower than the forecast US Biotechnology industry average of 30.96%.

What is VTYX's Price Target?

According to 5 Wall Street analysts that have issued a 1 year VTYX price target, the average VTYX price target is $9.80, with the highest VTYX stock price forecast at $16.00 and the lowest VTYX stock price forecast at $2.00.

On average, Wall Street analysts predict that Ventyx Biosciences's share price could reach $9.80 by Jun 6, 2025. The average Ventyx Biosciences stock price prediction forecasts a potential upside of 228.86% from the current VTYX share price of $2.98.

What is VTYX's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: VTYX) Ventyx Biosciences's current Earnings Per Share (EPS) is -$3.24. On average, analysts forecast that VTYX's EPS will be -$2.31 for 2024, with the lowest EPS forecast at -$2.65, and the highest EPS forecast at -$2.07. On average, analysts forecast that VTYX's EPS will be -$2.37 for 2025, with the lowest EPS forecast at -$3.11, and the highest EPS forecast at -$1.83. In 2026, VTYX's EPS is forecast to hit -$1.20 (min: -$2.48, max: $0.76).

What is VTYX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: VTYX) forecast ROE is 1.84%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.